Vidal LL, et al. NS3 protease polymorphisms and genetic barrier to drug resistance of distinct HCV genotypes from worldwide treatment-naive subjects. JVH, 2016, 23(11): 840-849.
Department of Gastroenterology, St. Vincent's Hospital and The University of Melbourne, Melbourne, Australia.
A J
AJ
Thompson
Victorian Infectious Diseases Reference Laboratory at the Doherty Institute, the University of Melbourne and Monash University, Melbourne, Australia.
D S
DS
Bowden
D000998:Antiviral Agents; D004351:Drug Resistance / Q000187:drug effects; D024882:Drug Resistance, Viral / Q000187:drug effects; D005838:Genotype; D016174:Hepacivirus / Q000187:drug effects*; D006526:Hepatitis C; D006801:Humans; D010447:Peptide Hydrolases / Q000235:genetics; D011480:Protease Inhibitors; D017361:Viral Nonstructural Proteins / Q000235:genetics*
D000998:Antiviral Agents; D011480:Protease Inhibitors; D017361:Viral Nonstructural Proteins; D010447:Peptide Hydrolases